{"activeTab":"BnXIg7Ru4SK5FpscX41b","articleCategories":[{"data":{"createdAt":{"_type":"Date","value":"Thu Jul 07 2022 16:34:53 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},"diseases":[{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},{"_type":"DocumentReference","path":"diseases/WCJo8IouncjDW6exT1YS"},{"_type":"DocumentReference","path":"diseases/cll"},{"_type":"DocumentReference","path":"diseases/t8f3E99OdM9XZe1d1ASM"},{"_type":"DocumentReference","path":"diseases/eBIxYtdHAYhTTs5L9bcC"},{"_type":"DocumentReference","path":"diseases/EkjGB5kileTKP2vnTWhV"},{"_type":"DocumentReference","path":"diseases/WNjIFmDibXhTFneCh4dG"},{"_type":"DocumentReference","path":"diseases/leukemia"},{"_type":"DocumentReference","path":"diseases/E7FvorVuNJjGzy9wH7fy"},{"_type":"DocumentReference","path":"diseases/chronic-myelomonocytic-leukemia"},{"_type":"DocumentReference","path":"diseases/hodgkin-lymphoma"},{"_type":"DocumentReference","path":"diseases/non-hodgkins-lymphoma"},{"_type":"DocumentReference","path":"diseases/lymphoma"},{"_type":"DocumentReference","path":"diseases/mantle-cell-lyphoma"},{"_type":"DocumentReference","path":"diseases/lymphoblastic-lymphoma"},{"_type":"DocumentReference","path":"diseases/tDYO4O8HTJT5dAHT6xis"}],"migratedReason":"global-community","migratedReason2":"fix global-community categories","migratedSlug":true,"oldSlug":"new-in-myeloma","sectionConfig":{"news":{"description":"Our Treatment Advances articles cover treatment option updates, new combinations of treatments, FDA approval news, and more.","metaDescription":"It's important for patients to stay up-to-speed on advancements in their cancer because the treatment options are rapidly changing.","metaTitle":"Treatment Advances - HealthTree Foundation","order":1,"tileOrder":1,"type":"LARGE_TILE"}},"sections":["NEWS"],"slug":"treatment-advances","status":"ACTIVE","title":"Treatment Advances","updatedAt":{"_type":"Date","value":"Fri Apr 12 2024 20:21:03 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/categories/haqKTOi9lG4MNU3rNLG6"},"snapshot":{"exists":true,"id":"haqKTOi9lG4MNU3rNLG6","ref":{"_type":"DocumentReference","path":"apps/community/categories/haqKTOi9lG4MNU3rNLG6"}}},{"data":{"createdAt":{"_type":"Date","value":"Sat Jul 30 2022 16:56:14 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},"diseases":[{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},{"_type":"DocumentReference","path":"diseases/WCJo8IouncjDW6exT1YS"},{"_type":"DocumentReference","path":"diseases/cll"},{"_type":"DocumentReference","path":"diseases/t8f3E99OdM9XZe1d1ASM"},{"_type":"DocumentReference","path":"diseases/eBIxYtdHAYhTTs5L9bcC"},{"_type":"DocumentReference","path":"diseases/EkjGB5kileTKP2vnTWhV"},{"_type":"DocumentReference","path":"diseases/WNjIFmDibXhTFneCh4dG"},{"_type":"DocumentReference","path":"diseases/leukemia"},{"_type":"DocumentReference","path":"diseases/E7FvorVuNJjGzy9wH7fy"},{"_type":"DocumentReference","path":"diseases/chronic-myelomonocytic-leukemia"},{"_type":"DocumentReference","path":"diseases/hodgkin-lymphoma"},{"_type":"DocumentReference","path":"diseases/non-hodgkins-lymphoma"},{"_type":"DocumentReference","path":"diseases/lymphoma"},{"_type":"DocumentReference","path":"diseases/mantle-cell-lyphoma"},{"_type":"DocumentReference","path":"diseases/lymphoblastic-lymphoma"},{"_type":"DocumentReference","path":"diseases/tDYO4O8HTJT5dAHT6xis"},{"_type":"DocumentReference","path":"diseases/essential-thrombocythemia"}],"migratedReason":"global-community","migratedReason2":"fix global-community categories","migratedSlug":true,"oldSlug":"fitness","sectionConfig":{"events":{"description":"Our Navigating Your Health events help you manage your wellness through diet, fitness, side effect management, survivorship, and life hacks that can improve your quality of life.","metaDescription":"Events you can join designed for navigating your health such as infection prevention, battling disparities, and survivorship.","metaTitle":"Navigating Your Health Events - HealthTree","order":1},"news":{"description":"Our Navigating Your Health articles can help you proactively take control of your health through wellness news, financial updates, healthy recipes, and more.","metaDescription":"Learn tips related to your overall wellness, including your mental, physical, and emotional health.","metaTitle":"Navigating Your Health - HealthTree Foundation","order":2},"podcasts":{"order":7,"status":"DRAFT"}},"sections":["EVENTS","NEWS"],"slug":"navigating-your-health","status":"ACTIVE","title":"Navigating Your Health","updatedAt":{"_type":"Date","value":"Thu Apr 25 2024 18:37:49 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/categories/hn1DyzeAyX6tgl3gxSDx"},"snapshot":{"exists":true,"id":"hn1DyzeAyX6tgl3gxSDx","ref":{"_type":"DocumentReference","path":"apps/community/categories/hn1DyzeAyX6tgl3gxSDx"}}},{"data":{"createdAt":{"_type":"Date","value":"Thu Jul 07 2022 16:34:03 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},"diseases":[{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},{"_type":"DocumentReference","path":"diseases/WCJo8IouncjDW6exT1YS"},{"_type":"DocumentReference","path":"diseases/cll"},{"_type":"DocumentReference","path":"diseases/t8f3E99OdM9XZe1d1ASM"},{"_type":"DocumentReference","path":"diseases/eBIxYtdHAYhTTs5L9bcC"},{"_type":"DocumentReference","path":"diseases/EkjGB5kileTKP2vnTWhV"},{"_type":"DocumentReference","path":"diseases/WNjIFmDibXhTFneCh4dG"},{"_type":"DocumentReference","path":"diseases/leukemia"},{"_type":"DocumentReference","path":"diseases/E7FvorVuNJjGzy9wH7fy"},{"_type":"DocumentReference","path":"diseases/chronic-myelomonocytic-leukemia"},{"_type":"DocumentReference","path":"diseases/hodgkin-lymphoma"},{"_type":"DocumentReference","path":"diseases/non-hodgkins-lymphoma"},{"_type":"DocumentReference","path":"diseases/lymphoma"},{"_type":"DocumentReference","path":"diseases/mantle-cell-lyphoma"},{"_type":"DocumentReference","path":"diseases/lymphoblastic-lymphoma"},{"_type":"DocumentReference","path":"diseases/tDYO4O8HTJT5dAHT6xis"}],"migratedReason":"global-community","migratedReason2":"fix global-community categories","migratedSlug":true,"oldSlug":"myeloma-basics","sectionConfig":{"news":{"description":"Our Core Education articles help you understand your cancer so you are equipped to find a good care team, ask appropriate questions, and become your own best advocate.","metaDescription":"Learn 101 Education to help you know more about your cancer, what tests and treatments are available to you, and more.","metaTitle":"Core Education - HealthTree Foundation","order":3,"tileOrder":3,"type":"LARGE_TILE"}},"sections":["NEWS"],"slug":"core-education","status":"ACTIVE","title":"Core Education","updatedAt":{"_type":"Date","value":"Fri Apr 12 2024 20:21:23 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/categories/MB3xw38fuKkx0LdszsrL"},"snapshot":{"exists":true,"id":"MB3xw38fuKkx0LdszsrL","ref":{"_type":"DocumentReference","path":"apps/community/categories/MB3xw38fuKkx0LdszsrL"}}},{"data":{"createdAt":{"_type":"Date","value":"Wed Jan 04 2023 22:59:47 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},"diseases":[{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},{"_type":"DocumentReference","path":"diseases/WCJo8IouncjDW6exT1YS"},{"_type":"DocumentReference","path":"diseases/cll"},{"_type":"DocumentReference","path":"diseases/t8f3E99OdM9XZe1d1ASM"},{"_type":"DocumentReference","path":"diseases/eBIxYtdHAYhTTs5L9bcC"},{"_type":"DocumentReference","path":"diseases/EkjGB5kileTKP2vnTWhV"},{"_type":"DocumentReference","path":"diseases/WNjIFmDibXhTFneCh4dG"},{"_type":"DocumentReference","path":"diseases/leukemia"},{"_type":"DocumentReference","path":"diseases/E7FvorVuNJjGzy9wH7fy"},{"_type":"DocumentReference","path":"diseases/chronic-myelomonocytic-leukemia"},{"_type":"DocumentReference","path":"diseases/hodgkin-lymphoma"},{"_type":"DocumentReference","path":"diseases/non-hodgkins-lymphoma"},{"_type":"DocumentReference","path":"diseases/lymphoma"},{"_type":"DocumentReference","path":"diseases/mantle-cell-lyphoma"},{"_type":"DocumentReference","path":"diseases/lymphoblastic-lymphoma"},{"_type":"DocumentReference","path":"diseases/tDYO4O8HTJT5dAHT6xis"},{"_type":"DocumentReference","path":"diseases/essential-thrombocythemia"}],"migratedReason":"global-community","migratedReason2":"fix global-community categories","migratedSlug":true,"oldSlug":"patient-stories","sectionConfig":{"news":{"description":"Our Patient Stories articles contain patient and caregiver experiences, along with their advice for others going through similar circumstances.","metaDescription":"Read patient stories to learn about other’s experiences and what advice they have for people going through similar circumstances.","metaTitle":"Patient Stories - HealthTree Foundation","order":4,"tileOrder":1,"type":"SMALL_TILE"}},"sections":["NEWS"],"slug":"patient-stories","status":"ACTIVE","title":"Patient Stories","updatedAt":{"_type":"Date","value":"Thu Apr 25 2024 18:37:43 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/categories/19hxT6XALz8ds00eORms"},"snapshot":{"exists":true,"id":"19hxT6XALz8ds00eORms","ref":{"_type":"DocumentReference","path":"apps/community/categories/19hxT6XALz8ds00eORms"}}},{"data":{"createdAt":{"_type":"Date","value":"Thu Jul 07 2022 16:36:49 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},"diseases":[{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},{"_type":"DocumentReference","path":"diseases/WCJo8IouncjDW6exT1YS"},{"_type":"DocumentReference","path":"diseases/cll"},{"_type":"DocumentReference","path":"diseases/t8f3E99OdM9XZe1d1ASM"},{"_type":"DocumentReference","path":"diseases/eBIxYtdHAYhTTs5L9bcC"},{"_type":"DocumentReference","path":"diseases/EkjGB5kileTKP2vnTWhV"},{"_type":"DocumentReference","path":"diseases/WNjIFmDibXhTFneCh4dG"},{"_type":"DocumentReference","path":"diseases/leukemia"},{"_type":"DocumentReference","path":"diseases/E7FvorVuNJjGzy9wH7fy"},{"_type":"DocumentReference","path":"diseases/chronic-myelomonocytic-leukemia"},{"_type":"DocumentReference","path":"diseases/hodgkin-lymphoma"},{"_type":"DocumentReference","path":"diseases/non-hodgkins-lymphoma"},{"_type":"DocumentReference","path":"diseases/lymphoma"},{"_type":"DocumentReference","path":"diseases/mantle-cell-lyphoma"},{"_type":"DocumentReference","path":"diseases/lymphoblastic-lymphoma"},{"_type":"DocumentReference","path":"diseases/tDYO4O8HTJT5dAHT6xis"},{"_type":"DocumentReference","path":"diseases/essential-thrombocythemia"}],"migratedReason":"global-community","migratedReason2":"fix global-community categories","migratedSlug":true,"oldSlug":"research","sectionConfig":{"events":{"description":"Our HealthTree Research events help you learn about the latest research and studies related to your cancer, including interviews with medical specialists.","metaDescription":"Research Events to help you learn about the latest research and studies related to your cancer, including interviews with medical specialists.","metaTitle":"(disease) Research Events - HealthTree Foundation","order":5},"news":{"description":"Our HealthTree Research articles contain findings from surveys and studies inside HealthTree’s database. These surveys and studies are conducted by researchers and specialists.","metaDescription":"These articles are findings from HealthTree Research findings from surveys and studies.","metaTitle":"HealthTree Research - HealthTree Foundation","order":5,"tileOrder":2,"type":"SMALL_TILE"},"podcasts":{"order":2,"status":"ACTIVE"}},"sections":["EVENTS","NEWS"],"slug":"research","status":"ACTIVE","title":"HealthTree Research","updatedAt":{"_type":"Date","value":"Thu Apr 25 2024 18:37:49 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/categories/BnXIg7Ru4SK5FpscX41b"},"snapshot":{"exists":true,"id":"BnXIg7Ru4SK5FpscX41b","ref":{"_type":"DocumentReference","path":"apps/community/categories/BnXIg7Ru4SK5FpscX41b"}}},{"data":{"createdAt":{"_type":"Date","value":"Sat Dec 02 2023 00:52:31 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},"diseases":[{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},{"_type":"DocumentReference","path":"diseases/WCJo8IouncjDW6exT1YS"},{"_type":"DocumentReference","path":"diseases/cll"},{"_type":"DocumentReference","path":"diseases/t8f3E99OdM9XZe1d1ASM"},{"_type":"DocumentReference","path":"diseases/eBIxYtdHAYhTTs5L9bcC"},{"_type":"DocumentReference","path":"diseases/EkjGB5kileTKP2vnTWhV"},{"_type":"DocumentReference","path":"diseases/WNjIFmDibXhTFneCh4dG"},{"_type":"DocumentReference","path":"diseases/leukemia"},{"_type":"DocumentReference","path":"diseases/E7FvorVuNJjGzy9wH7fy"},{"_type":"DocumentReference","path":"diseases/chronic-myelomonocytic-leukemia"},{"_type":"DocumentReference","path":"diseases/hodgkin-lymphoma"},{"_type":"DocumentReference","path":"diseases/non-hodgkins-lymphoma"},{"_type":"DocumentReference","path":"diseases/lymphoma"},{"_type":"DocumentReference","path":"diseases/mantle-cell-lyphoma"},{"_type":"DocumentReference","path":"diseases/lymphoblastic-lymphoma"},{"_type":"DocumentReference","path":"diseases/tDYO4O8HTJT5dAHT6xis"}],"migratedReason":"global-community","migratedReason2":"fix global-community categories","migratedSlug":true,"oldSlug":"conferences","sectionConfig":{"news":{"description":"Our Conferences articles contain the latest coverage of medical advancements from recent academic conferences.","metaDescription":"These articles discuss the latest coverage of medical advancements from recent academic conferences.","metaTitle":"Conferences - HealthTree Foundation","order":6,"tileOrder":3,"type":"SMALL_TILE"}},"sections":["NEWS"],"slug":"conferences","status":"ACTIVE","title":"Conferences","updatedAt":{"_type":"Date","value":"Fri Apr 12 2024 20:21:44 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/categories/j4bWXiDzhdlhMFvaeXoc"},"snapshot":{"exists":true,"id":"j4bWXiDzhdlhMFvaeXoc","ref":{"_type":"DocumentReference","path":"apps/community/categories/j4bWXiDzhdlhMFvaeXoc"}}},{"data":{"createdAt":{"_type":"Date","value":"Thu Jul 07 2022 16:35:12 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},"diseases":[{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},{"_type":"DocumentReference","path":"diseases/WCJo8IouncjDW6exT1YS"},{"_type":"DocumentReference","path":"diseases/cll"},{"_type":"DocumentReference","path":"diseases/t8f3E99OdM9XZe1d1ASM"},{"_type":"DocumentReference","path":"diseases/eBIxYtdHAYhTTs5L9bcC"},{"_type":"DocumentReference","path":"diseases/EkjGB5kileTKP2vnTWhV"},{"_type":"DocumentReference","path":"diseases/WNjIFmDibXhTFneCh4dG"},{"_type":"DocumentReference","path":"diseases/leukemia"},{"_type":"DocumentReference","path":"diseases/E7FvorVuNJjGzy9wH7fy"},{"_type":"DocumentReference","path":"diseases/chronic-myelomonocytic-leukemia"},{"_type":"DocumentReference","path":"diseases/hodgkin-lymphoma"},{"_type":"DocumentReference","path":"diseases/non-hodgkins-lymphoma"},{"_type":"DocumentReference","path":"diseases/lymphoma"},{"_type":"DocumentReference","path":"diseases/mantle-cell-lyphoma"},{"_type":"DocumentReference","path":"diseases/lymphoblastic-lymphoma"},{"_type":"DocumentReference","path":"diseases/tDYO4O8HTJT5dAHT6xis"},{"_type":"DocumentReference","path":"diseases/essential-thrombocythemia"}],"migratedReason":"global-community","migratedReason2":"fix global-community categories","migratedSlug":true,"oldSlug":"clinical-trials","sectionConfig":{"news":{"description":"Our Clinical Trials articles highlight top clinical trials, their results, and how patients can participate in them.","metaDescription":"These articles highlight top clinical trials, their results, and how patients can participate in them.","metaTitle":"Clinical Trials - HealthTree Foundation","order":7,"tileOrder":4,"type":"SMALL_TILE"}},"sections":["NEWS"],"slug":"clinical-trials","status":"ACTIVE","title":"Clinical Trials","updatedAt":{"_type":"Date","value":"Thu Apr 25 2024 18:37:47 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/categories/hUncpyMvyuZCF2qvA0Cv"},"snapshot":{"exists":true,"id":"hUncpyMvyuZCF2qvA0Cv","ref":{"_type":"DocumentReference","path":"apps/community/categories/hUncpyMvyuZCF2qvA0Cv"}}},{"data":{"createdAt":{"_type":"Date","value":"Thu Jul 07 2022 16:35:26 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},"diseases":[{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},{"_type":"DocumentReference","path":"diseases/WCJo8IouncjDW6exT1YS"},{"_type":"DocumentReference","path":"diseases/cll"},{"_type":"DocumentReference","path":"diseases/t8f3E99OdM9XZe1d1ASM"},{"_type":"DocumentReference","path":"diseases/eBIxYtdHAYhTTs5L9bcC"},{"_type":"DocumentReference","path":"diseases/EkjGB5kileTKP2vnTWhV"},{"_type":"DocumentReference","path":"diseases/WNjIFmDibXhTFneCh4dG"},{"_type":"DocumentReference","path":"diseases/leukemia"},{"_type":"DocumentReference","path":"diseases/E7FvorVuNJjGzy9wH7fy"},{"_type":"DocumentReference","path":"diseases/chronic-myelomonocytic-leukemia"},{"_type":"DocumentReference","path":"diseases/hodgkin-lymphoma"},{"_type":"DocumentReference","path":"diseases/non-hodgkins-lymphoma"},{"_type":"DocumentReference","path":"diseases/lymphoma"},{"_type":"DocumentReference","path":"diseases/mantle-cell-lyphoma"},{"_type":"DocumentReference","path":"diseases/lymphoblastic-lymphoma"},{"_type":"DocumentReference","path":"diseases/tDYO4O8HTJT5dAHT6xis"},{"_type":"DocumentReference","path":"diseases/essential-thrombocythemia"}],"migratedReason":"global-community","migratedReason2":"fix global-community categories","migratedSlug":true,"oldSlug":"healthtree","sectionConfig":{"news":{"description":"Our HealthTree Programs articles highlight the programs, events, and updates of the HealthTree Foundation.","metaDescription":"These articles highlight the programs, events, and updates of the HealthTree Foundation.","metaTitle":"HealthTree Programs - HealthTree Foundation","order":8,"tileOrder":6,"type":"SMALL_TILE"}},"sections":["NEWS"],"slug":"healthtree-programs","status":"ACTIVE","title":"HealthTree Programs","updatedAt":{"_type":"Date","value":"Thu Apr 25 2024 18:37:52 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/categories/WSTraX4hOKp92asdiTHa"},"snapshot":{"exists":true,"id":"WSTraX4hOKp92asdiTHa","ref":{"_type":"DocumentReference","path":"apps/community/categories/WSTraX4hOKp92asdiTHa"}}},{"data":{"createdAt":{"_type":"Date","value":"Thu Jul 07 2022 16:35:51 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},"diseases":[{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},{"_type":"DocumentReference","path":"diseases/WCJo8IouncjDW6exT1YS"},{"_type":"DocumentReference","path":"diseases/cll"},{"_type":"DocumentReference","path":"diseases/eBIxYtdHAYhTTs5L9bcC"},{"_type":"DocumentReference","path":"diseases/EkjGB5kileTKP2vnTWhV"},{"_type":"DocumentReference","path":"diseases/WNjIFmDibXhTFneCh4dG"},{"_type":"DocumentReference","path":"diseases/leukemia"},{"_type":"DocumentReference","path":"diseases/E7FvorVuNJjGzy9wH7fy"},{"_type":"DocumentReference","path":"diseases/chronic-myelomonocytic-leukemia"},{"_type":"DocumentReference","path":"diseases/hodgkin-lymphoma"},{"_type":"DocumentReference","path":"diseases/non-hodgkins-lymphoma"},{"_type":"DocumentReference","path":"diseases/lymphoma"},{"_type":"DocumentReference","path":"diseases/mantle-cell-lyphoma"},{"_type":"DocumentReference","path":"diseases/lymphoblastic-lymphoma"},{"_type":"DocumentReference","path":"diseases/tDYO4O8HTJT5dAHT6xis"},{"_type":"DocumentReference","path":"diseases/t8f3E99OdM9XZe1d1ASM"},{"_type":"DocumentReference","path":"diseases/essential-thrombocythemia"}],"migratedReason":"global-community","migratedReason2":"fix global-community categories","migratedSlug":true,"oldSlug":"healthtree-press","sectionConfig":{"news":{"description":"Read articles about HealthTree's progress in major media publications in video, online and in newspapers.","metaDescription":"These articles are about HealthTree's progress in major media publications in video, online and in newspapers.","metaTitle":"HealthTree Press - HealthTree Myeloma","order":9,"tileOrder":5,"type":"SMALL_TILE"}},"sections":["NEWS"],"slug":"healthtree-press","status":"ACTIVE","title":"HealthTree Press","updatedAt":{"_type":"Date","value":"Thu Apr 25 2024 18:37:51 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/categories/SOL2ODcbaDI1CazQRbRS"},"snapshot":{"exists":true,"id":"SOL2ODcbaDI1CazQRbRS","ref":{"_type":"DocumentReference","path":"apps/community/categories/SOL2ODcbaDI1CazQRbRS"}}}],"articlesToDisplay":[{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/Yj5pk904HRNwZA8Wqfcu"},"category":{"_type":"DocumentReference","path":"apps/community/categories/BnXIg7Ru4SK5FpscX41b"},"createdAt":{"_type":"Date","value":"Tue Sep 17 2024 18:25:08 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/GMiulNhUPGrzlsCN3Fmv"},"diseases":[{"_type":"DocumentReference","path":"diseases/GMiulNhUPGrzlsCN3Fmv"},{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2Fsafe%20digital%20health_01b567be-bb9e-4f41-900a-01c638f7420f.jpg?alt=media","htmlContent":"

During Blood Cancer Awareness Month, we're highlighting the impactful efforts of HealthTree Foundation in blood cancers. At HealthTree, we are dedicated to empowering patients with knowledge, connecting them to cutting-edge research, and fostering a supportive community.

\n\n

HealthTree Cure Hub: Accelerating Cures Through Patient-Driven Research

\n\n

At the heart of HealthTree's innovation is HealthTree Cure Hub, a platform that's revolutionizing blood cancer research. HealthTree Cure Hub connects patients directly to clinical trials, accelerating the development of new treatments. But it goes beyond trials. By gathering real-world data and patient-reported outcomes, HealthTree Cure Hub provides researchers with invaluable insights that are shaping the future of blood cancer care.

\n\n

Continue Exploring All the Benefits of HealthTree Cure Hub

\n\n

Real-World Impact: Examples of HealthTree Research

\n\n

HealthTree Foundation is actively contributing to blood cancer research. For example, a recent study reported on real-world experiences of patients undergoing some specific myeloma treatments, including the treatment decision-making process, patients' expectations and evaluation of treatment, and patient perspectives and information needs related to CAR T-cell therapies and bispecific antibodies.

\n\n

We also recently shared the results of the use of cannabis to manage pain and anxiety and the use of dietary supplements in patients with multiple myeloma, what motivates these patients to use supplements, and where they get their information about them.

\n\n

HealthTree Cure Hub is facilitating research in different stages of the treatment, such as the ongoing study on stem cell mobilization in patients undergoing a stem cell transplant. This research will help understand the challenges and hopefully improve the stem cell collection process for patients.

\n\n

Participate in Blood Cancer Research, Become a Cure Contributor

\n\n

HealthTree Cure Hub empowers patients to become active participants in research. By connecting your medical records, participating in surveys, and contributing to studies, you provide researchers with critical data that can lead to breakthroughs in blood cancer treatment.

\n\n

Create a free account and explore our open patient surveys here:

\n\n

JOIN/LOG IN TO HEALTHTREE CURE HUB

\n\n

!AD!

\n\n

Empowering Patients Through Knowledge and Connection

\n\n

At HealthTree, we understand that knowledge is power. Through our website and educational resources, HealthTree provides patients and their loved ones with trustworthy information about their specific blood cancer, treatment options, and managing side effects.

\n\n

But HealthTree is more than just information; it's a community. Through our online forums and webinars, patients can connect with others facing similar challenges, share experiences, and find support.

\n\n

Learn More About Blood Cancer

\n\n

HealthTree's Coach Program pairs newly diagnosed patients with trained volunteer coaches who have navigated similar diagnoses, providing personalized guidance and support.

\n\n

Join the HealthTree Community

\n\n

!AD!

\n\n

Expanding Support for All Blood Cancers

\n\n

While HealthTree Foundation began as a myeloma-focused organization, it has expanded its reach to support all blood cancers. We are currently most active in:

\n\n

!AD!

\n\n

We encourage all blood cancer patients and their loved ones to join our growing community. Together, we can make a difference.

\n\n

HealthTree Foundation: Innovation that saves lives

\n","language":"EN","metaDescription":"HealthTree Foundation empowers patients and accelerates cures for blood cancers through innovative, patient-driven research and a supportive community.","metaTitle":"HealthTree and Blood Cancer Research","publishedAt":{"_type":"Date","value":"Wed Sep 18 2024 04:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"what awareness month is september, awareness months, what is september awareness month, blood cancer awareness month 2024, cancer, cancer awareness, blood cancer research, HealthTree Foundation, Cure Hub, patient-centered research, clinical trials, blood cancer community, patient support, blood cancer awareness month","slug":"bcam-2024-healthtree-research-real-world-data","status":"ACTIVE","title":"Revolutionizing Blood Cancer Care: HealthTree Foundation's Commitment to Innovation","updatedAt":{"_type":"Date","value":"Thu Sep 19 2024 17:11:53 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/0MpzbYB5fHWjfCsmW2KD"},"snapshot":{"exists":true,"id":"0MpzbYB5fHWjfCsmW2KD","ref":{"_type":"DocumentReference","path":"apps/community/articles/0MpzbYB5fHWjfCsmW2KD"}}},{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/GxAhXAnh3drV4xY5Vf3A-1620"},"categories":[{"_type":"DocumentReference","path":"apps/community/articleCategories/AJBVFq5YlnsCqpmYX3Nh"}],"category":{"_type":"DocumentReference","path":"apps/community/categories/BnXIg7Ru4SK5FpscX41b"},"createdAt":{"_type":"Date","value":"Mon Apr 22 2024 22:27:32 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/cll"},"diseases":[{"_type":"DocumentReference","path":"diseases/cll"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FCure%20Hub%20Article%20Cover_59302611-fb66-4ae6-81e1-2eed6a0bcafd.png?alt=media","htmlContent":"

More patient data within HealthTree Cure Hub means more accurate results for blood cancer research.

\n\n

We encourage you to invite other CLL patients within your circle to connect their medical records to HealthTree Cure Hub so that they can participate in real-world CLL research and also receive the many personal benefits that come from being a part of this patient database and portal.

\n\n

!AD!

\n\n

Benefits of HealthTree Cure Hub for CLL Patients

\n\n

You can benefit from HealthTree Cure Hub by:

\n\n

Tracking Your CLL Labs
Searching Solutions to Your Side Effects
Participating in CLL Research
Searching for CLL Clinical Trials
Finding Your CLL Twin

\n\n

!AD!

\n\n

How To Share HealthTree Cure Hub Within Your CLL Circle

\n\n

Ask us to share more about HealthTree Cure Hub at your local support group. We can present virtually to your group and explain the benefits and why it's important to blood cancer research.
We can present a virtual webinar to people within your circle (outside of a support group), if you want to host a virtual get-together with people from your clinic or treatment center.
You can request pamphlets/brochures from us to send to your local clinic or academic center. Just email sofia@healthtree.org.

\n\n

Thank you for being willing to participate in and spread the word about HealthTree Cure Hub. The more people we have as a part of our database, the more accurate CLL research can be done.

\n\n

!AD!

\n","language":"EN","metaDescription":"HealthTree Cure Hub is a great way to get CLL patients involved in research, as well as get benefits for themselves. Learn more here.","metaTitle":"Share HealthTree Cure Hub for CLL Research","oldAuthor":{"_type":"DocumentReference","path":"apps/community/authors/dgpNLrVI0YJktfzGS0Ua"},"publishedAt":{"_type":"Date","value":"Mon Jun 03 2024 04:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"healthtree cure hub, ht cure hub, cure hub, cll research, how can i participate in cll research, cll clinical trials","slug":"share-healthtree-cure-hub-cll","status":"ACTIVE","title":"Share HealthTree Cure Hub to Accelerate CLL Research","updatedAt":{"_type":"Date","value":"Mon Jun 03 2024 22:41:20 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/kRV9gjqJlnw4GGRrz7d5"},"snapshot":{"exists":true,"id":"kRV9gjqJlnw4GGRrz7d5","ref":{"_type":"DocumentReference","path":"apps/community/articles/kRV9gjqJlnw4GGRrz7d5"}}},{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/GxAhXAnh3drV4xY5Vf3A-1620"},"categories":[{"_type":"DocumentReference","path":"apps/community/articleCategories/AJBVFq5YlnsCqpmYX3Nh"}],"category":{"_type":"DocumentReference","path":"apps/community/categories/BnXIg7Ru4SK5FpscX41b"},"createdAt":{"_type":"Date","value":"Mon Mar 11 2024 17:20:49 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/cll"},"diseases":[{"_type":"DocumentReference","path":"diseases/cll"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FHealth%20History_ce09d726-a2cc-486c-8b2f-654ae04fb720.jpg?alt=media","htmlContent":"

Do your part to accelerate blood cancer research by participating in one of our health history surveys. These surveys help researchers understand a better overall picture of their patients' current health, health history, and quality of life.

\n\n

Completing these surveys also helps HealthTree Foundation understand your current health, so that we know what personalized treatment recommendations and clinical trials to give to you in your HealthTree Cure Hub profile. This is a huge benefit that can simplify your treatment plans for chronic lymphocytic leukemia.

\n\n

By contributing to these surveys, you are adding important information to our research database. The more information that researchers have, the more accurate their data pulls will be when analyzing CLL patients, their health, and their outcomes.

\n\n

Listed below are seven health surveys with details about each one. You can choose to take one or more of these surveys to contribute to our patient database.

\n\n

Please note that before shared with researchers, your data is anonymized. We value your privacy and are grateful for your contributions.

\n\n

How Can I Take These Surveys?

\n\n

You will need a HealthTree Cure Hub account to participate in these surveys. If you don't have a HealthTree Cure Hub account, you can sign up for free today.

\n\n

My Current Health

\n\n

Description: This is a HealthTree Survey about your current health status. We ask that you please keep this updated as your health condition changes over time.
What it asks: this survey asks about any heart, lung, bone, kidney, diabetes, blood pressure, blood clot (DVT), neuropathy, infections, and anxiety conditions. It also asks about your ability to walk/exercise, shop for groceries, or prepare meals without help, whether or not you have a caregiver, your stem cell transplant eligibility, and the current status of your CLL.
Time: This survey should take you about six (6) minutes.

\n\n

Health History: Heart and Lungs

\n\n

Description: A HealthTree survey regarding your cardiovascular and pulmonary system health history.
What it asks: this survey asks about your history of any cardiovascular disorders including hypertension, abnormal heart rhythms or arrhythmia, Deep venous thrombosis (DVT), brain stroke, pulmonary embolism, heart failure, myocardial infarction, coronary artery disease, peripheral artery disease, aneurysm or other blood clot conditions. It also asks about your history with pulmonary disorders such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary emphysema, sleep apnea, and recurrent pneumonia.
Time: This survey should take you about seven (7) minutes.

\n\n

Heart and Metabolic Family History

\n\n

Description: A HealthTree survey about your family health history.
What it asks: This survey asks about your family history with cardiovascular disease such as high blood pressure, heart attack, heart failure, arrhythmia, atrial fibrillation, heart valve complication, stroke, pulmonary embolism, deep vein thrombosis (DVT), peripheral vascular disease, or other health complication. It also asks about any family history of metabolic disease such as diabetes type 1 or type 2, metabolic syndrome, obesity, hypercholesterolemia, or another metabolic disease.
Time: Depending on your answers, this survey could take you up to 8 (eight) minutes.

\n\n

Cancer Family History

\n\n

Description: A HealthTree survey about your family's history with cancer.
What it asks: This survey asks about your family's history with any of the following cancers: bladder, breast, brain, colon, colorectal, Hodgkin's disease, kidney, leukemia, liver, lung, lymphoma, melanoma, mouth/throat, pancreatic, prostate, rectal, sarcoma, stomach, thyroid, uterine/endometrial, unknown, other, cervical, or ovarian.
Time: Depending on your answers and knowledge of cancer family history, this survey could take you up to 10 minutes.

\n\n

Health History: General and Immune

\n\n

Description: A HealthTree survey about your blood type, allergies, autoimmune conditions, or chronic infections.
What it asks: This survey asks you to identify your blood type, if you have been diagnosed with connective tissue disease, ulcer disease, any food, drug, insect, latex, mold, pet, or pollen allergies, any autoimmune disorders such as AIDS, autoimmune anemia, cerebrovascular disease, Hashimoto's thyroiditis, Grave's disease, psoriasis, lupus, inflammatory bowel disease, Raynaud's syndrome, scleroderma, Sjögren's syndrome, MS (multiple sclerosis), Fibromyalgia, or another autoimmune disorder. Finally, it asks about any chronic infections such as HIV, Hepatitis B or C, mono, COVID-19, shingles, or another chronic infection.
Time: This survey will take you about 14 minutes to complete.

\n\n

Health History: Kidney, Intestines, Skeletal, etc.

\n\n

Description: A HealthTree survey about related health conditions, including diabetes, thyroid, kidney, gastrointestinal, neurological, and musculoskeletal issues (including osteonecrosis of the jaw).
What it asks: This survey asks if you have ever been diagnosed with diabetes, hyperlipidemia, thyroid disease, kidney, gastrointestinal, neurological, or musculoskeletal disorders.
Time: Depending on your answers, this survey could take you up to 15 minutes.

\n\n

Health History: Surgeries, Other Cancers, Mental Health

\n\n

Description: A HealthTree survey about past surgeries, other cancer diagnoses you may have, and any other related mental health concerns.
What it asks: This survey asks if you have had any of the following surgeries: appendectomy, gallbladder removal, hysterectomy, hernia repair, mastectomy, C-section, prostatectomy, cataract removal, joint replacement, broken bone repair, heart bypass surgery, stent procedure, angioplasty, or any other surgeries. It also asks about other non-CLL cancer-related diagnoses like basal cell carcinoma and the other cancers listed above. Finally, it asks about mental health disorders such as depression, anxiety/panic attacks or PTSD, insomnia, or other mental health conditions.
Time: Depending on your answers, this survey could take up to 30 minutes of your time.

\n\n

If you have any questions or concerns about the surveys, you can contact our HealthTree Patient Navigators (support@healthtree.org).

\n\n

Thank you for being willing to contribute to CLL research!

\n","language":"EN","metaDescription":"CLL patients are invited to take one or more health surveys to help researchers understand their patients' health profile and quality of life.","metaTitle":"CLL Research Survey: Health History ","migratedReason":"global-community","migratedReason2":"fix global-community categories","oldAuthor":{"_type":"DocumentReference","path":"apps/community/authors/dgpNLrVI0YJktfzGS0Ua"},"oldCategory":{"_type":"DocumentReference","path":"apps/community/categories/jB19cEpHSId89RF0gT1e"},"publishedAt":{"_type":"Date","value":"Wed May 29 2024 06:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"cll research, how can i participate in cll research, how to participate in cll research, cll health history, cll health","slug":"participate-in-cll-research-health-history-survey","status":"ACTIVE","title":"Participate in CLL Research: Health History Surveys","updatedAt":{"_type":"Date","value":"Thu May 30 2024 20:35:57 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/ru1KSOqxWjcwlK3iFjyn"},"snapshot":{"exists":true,"id":"ru1KSOqxWjcwlK3iFjyn","ref":{"_type":"DocumentReference","path":"apps/community/articles/ru1KSOqxWjcwlK3iFjyn"}}},{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/GxAhXAnh3drV4xY5Vf3A-1620"},"categories":[{"_type":"DocumentReference","path":"apps/community/articleCategories/AJBVFq5YlnsCqpmYX3Nh"}],"category":{"_type":"DocumentReference","path":"apps/community/categories/BnXIg7Ru4SK5FpscX41b"},"createdAt":{"_type":"Date","value":"Mon Apr 22 2024 22:20:47 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/cll"},"diseases":[{"_type":"DocumentReference","path":"diseases/cll"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2Ftransportation_00600051-8831-4554-82c0-a5f73fe9f8ee.jpg?alt=media","htmlContent":"

Chronic lymphocytic leukemia patients use various modes of transportation to get to their CLL appointments- but how does transportation affect CLL care?

\n\n

Participate in this four-minute, six-question survey to help blood cancer researchers better understand how consistent access to transportation affects cancer care.

\n\n

Many patients don't have access to support (such as caregivers), public transportation (such as taxis, buses, or metros), or financial means (for gas or transport) to afford proper CLL care.

\n\n

How can this affect CLL outcomes? Regardless of what kind of transportation you use and have access to, please take this survey so researchers can better understand how the CLL population as a whole uses transportation and how it affects their ability to attend appointments.

\n\n

Transportation Survey

\n\n

The information you submit is protected and private and will be shared anonymously with researchers. We value your privacy and are grateful for your contributions.

\n\n

If you have any questions or concerns about the survey, you can contact our HealthTree Patient Navigators (email support@healthtree.org or call/text +1(800) 709-1113).

\n\n

If you don't have a HealthTree Cure Hub account, you can sign up for free today.

\n","language":"EN","metaDescription":"Chronic lymphocytic leukemia patients can take a 4-minute, 6-question survey to help researchers understand how transportation access affects cancer care.","metaTitle":"CLL Research Survey: Transportation","oldAuthor":{"_type":"DocumentReference","path":"apps/community/authors/dgpNLrVI0YJktfzGS0Ua"},"publishedAt":{"_type":"Date","value":"Thu May 23 2024 04:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"cll research, how can i participate in cll research, how to participate in cll research, cll care, cll appointments, how to get to your cll appointment, equal treatment in cll","slug":"transportation-survey-highlight-cll","status":"ACTIVE","title":"Participate in CLL Research: Transportation Survey","updatedAt":{"_type":"Date","value":"Fri May 24 2024 16:20:39 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/g8kTUYSGvxnR8IwPgYxv"},"snapshot":{"exists":true,"id":"g8kTUYSGvxnR8IwPgYxv","ref":{"_type":"DocumentReference","path":"apps/community/articles/g8kTUYSGvxnR8IwPgYxv"}}},{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/dtN24frUcPS1CRElyXh1"},"categories":[{"_type":"DocumentReference","path":"apps/community/articleCategories/AJBVFq5YlnsCqpmYX3Nh"}],"category":{"_type":"DocumentReference","path":"apps/community/categories/BnXIg7Ru4SK5FpscX41b"},"createdAt":{"_type":"Date","value":"Mon Apr 22 2024 22:14:34 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/cll"},"diseases":[{"_type":"DocumentReference","path":"diseases/cll"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2Fshutterstock_446690704_3c7b0f22-06bd-46bf-bca3-2715142111b7.jpg?alt=media","htmlContent":"

Does the use of alcohol, tobacco, or drugs impact a CLL diagnosis or its progression? What about environmental exposure to different chemicals like cleaning products or pesticides?

\n\n

CLL patients are invited to accelerate research toward a better CLL treatment and cure by participating in surveys like this brief six-minute assessment. The data gathered will help researchers understand how substance use and environmental exposures may impact CLL development and progression.

\n\n

The information you submit is protected and private and will be shared anonymously with researchers. We value your privacy and are grateful for your contributions.

\n\n

Take the Substance Use and Environmental Exposure Survey

\n\n

If you have any questions or concerns about the survey, you can contact our HealthTree Patient Navigators (email support@healthtree.org or call/text (800)709-1113).

\n\n

If you don't have a HealthTree Cure Hub account, you can sign up for free today.

\n\n

We also invite you to securely connect your medical records to HealthTree Cure Hub. Doing so will help researchers answer questions like whether substance use or environmental exposures impact the amount of time between a patient’s diagnosis and starting treatment.

\n\n

Securely Connect My Medical Records to HealthTree Cure Hub

\n","language":"EN","metaDescription":"CLL patients are invited to take this six-minute survey to contribute to research on substance use and environmental exposure.","metaTitle":"CLL Research Survey: Substance Use and Exposure","oldAuthor":{"_type":"DocumentReference","path":"apps/community/authors/xByWWvI42oUh3A80DUjH"},"publishedAt":{"_type":"Date","value":"Wed May 22 2024 04:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"cll research, how can i participate in cll research, how to participate in myeloma research, CLL Patient Survey, Substance Use and CLL, Environmental Exposure and CLL, CLL Risk Factors","slug":"substance-use-survey-cll","status":"ACTIVE","title":"Participate in CLL Research: Substance Use and Environmental Exposure Survey","updatedAt":{"_type":"Date","value":"Wed May 22 2024 17:48:24 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/Aji0XUzVjOR8C4iBZS1f"},"snapshot":{"exists":true,"id":"Aji0XUzVjOR8C4iBZS1f","ref":{"_type":"DocumentReference","path":"apps/community/articles/Aji0XUzVjOR8C4iBZS1f"}}},{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/GxAhXAnh3drV4xY5Vf3A-1620"},"categories":[{"_type":"DocumentReference","path":"apps/community/articleCategories/AJBVFq5YlnsCqpmYX3Nh"}],"category":{"_type":"DocumentReference","path":"apps/community/categories/BnXIg7Ru4SK5FpscX41b"},"createdAt":{"_type":"Date","value":"Mon Apr 22 2024 22:01:08 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/cll"},"diseases":[{"_type":"DocumentReference","path":"diseases/cll"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2Fvaccines_d131bb76-a251-4e24-8c80-e131e7b68697.jpg?alt=media","htmlContent":"

HealthTree Foundation is promoting easier ways to participate in CLL research this month. Learn of a quick, easy opportunity below.

\n\n

Vaccinations are one of the best ways that immunocompromised CLL patients can protect their health. However, vaccinations and vaccination schedules are not currently standardized within CLL treatment/practices.

\n\n

By filling out this 1-minute, 3-question survey, you can contribute to blood cancer research to help specialists better understand what vaccinations contribute to the best protection or outcomes for chronic lymphocytic leukemia patients.

\n\n

Take the Vaccinations Survey

\n\n

The information you submit is protected and private and will be shared anonymously with researchers. We value your privacy and are grateful for your contributions.

\n\n

If you have any questions or concerns about the survey, you can contact our HealthTree Patient Navigators (email support@healthtree.org or call/text +1 (800) 709-1113).

\n\n

If you don't have a HealthTree Cure Hub account, you can sign up for free today.

\n","language":"EN","metaDescription":"CLL patients are invited to take this one-minute, three-question survey to contribute to research around vaccinations.","metaTitle":"CLL Research Survey: Vaccinations","oldAuthor":{"_type":"DocumentReference","path":"apps/community/authors/dgpNLrVI0YJktfzGS0Ua"},"publishedAt":{"_type":"Date","value":"Thu May 16 2024 04:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"cll research, how can i participate in cll research, how to participate in cll research, myeloma vaccinations, vaccinations, how to join cll research","slug":"vaccinations-survey-highlight-cll","status":"ACTIVE","title":"Participate in CLL Research: Vaccinations Survey","updatedAt":{"_type":"Date","value":"Thu May 16 2024 23:12:21 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/tXdh0dXngaaKw2j45VQa"},"snapshot":{"exists":true,"id":"tXdh0dXngaaKw2j45VQa","ref":{"_type":"DocumentReference","path":"apps/community/articles/tXdh0dXngaaKw2j45VQa"}}},{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/dtN24frUcPS1CRElyXh1"},"categories":[{"_type":"DocumentReference","path":"apps/community/articleCategories/AJBVFq5YlnsCqpmYX3Nh"}],"category":{"_type":"DocumentReference","path":"apps/community/categories/BnXIg7Ru4SK5FpscX41b"},"createdAt":{"_type":"Date","value":"Mon Apr 22 2024 21:38:41 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/cll"},"diseases":[{"_type":"DocumentReference","path":"diseases/cll"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2Fshutterstock_722718097_620799b1-62c9-4a12-8737-fe5f5781e2eb.jpg?alt=media","htmlContent":"

Do Diet and Alternative Therapies Influence CLL Progression? Help Us Find Out!

\n\n

Have you ever wondered if what you eat or alternative therapies you have tried help lower the chance of your CLL progressing? With your help, we can find answers to these questions.

\n\n

HealthTree Foundation is focusing on accelerating CLL research to advance cures. We need your help to contribute to research by participating in simple surveys. Doing so will help us gather enough data to determine if there are correlations between areas like CLL progression, diet, and alternative therapies.

\n\n

By filling out this six-minute survey, you can aid CLL researchers in answering key questions such as:

\n\n

Do dietary changes affect disease progression?
Does the use of dietary supplements affect disease progression?
Do sleep habits affect disease progression?
Do alternative therapies (such as acupressure) affect disease progression?

\n\n

Help us move closer to a cure by contributing your information in just six minutes!

\n\n

Take the Diet and Alternative Therapy Survey

\n\n

Please note that before shared with researchers, your data is anonymized. We value your privacy and are grateful for your contributions.

\n\n

If you have any questions or concerns about the survey, you can contact our HealthTree Patient Navigators (support@healthtree.org or (800) 709-1113).

\n\n

If you don't have a HealthTree Cure Hub account, you can sign up for free today.

\n","language":"EN","metaDescription":"CLL patients are invited to take a six-minute survey to help researchers understand if diet and alternative therapies impact disease outcomes.","metaTitle":"CLL Research: Diet & Alternative Therapy Survey","oldAuthor":{"_type":"DocumentReference","path":"apps/community/authors/xByWWvI42oUh3A80DUjH"},"publishedAt":{"_type":"Date","value":"Mon May 13 2024 04:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"CLL research, how to participate in CLL research, how can i do CLL research, healthtree for cll, healthtree, diet cll, food impact on cll ","slug":"cll-research-diet-alternative-therapy-survey","status":"ACTIVE","title":"Participate in CLL Research: Diet and Alternative Therapy Survey","updatedAt":{"_type":"Date","value":"Mon May 13 2024 15:40:29 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/SbP7RD3SMNwyhrm8Mq4G"},"snapshot":{"exists":true,"id":"SbP7RD3SMNwyhrm8Mq4G","ref":{"_type":"DocumentReference","path":"apps/community/articles/SbP7RD3SMNwyhrm8Mq4G"}}},{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/GxAhXAnh3drV4xY5Vf3A-1620"},"categories":[{"_type":"DocumentReference","path":"apps/community/articleCategories/AJBVFq5YlnsCqpmYX3Nh"}],"category":{"_type":"DocumentReference","path":"apps/community/categories/BnXIg7Ru4SK5FpscX41b"},"createdAt":{"_type":"Date","value":"Thu May 09 2024 23:03:21 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/cll"},"diseases":[{"_type":"DocumentReference","path":"diseases/cll"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2Fresearch_67dafd1d-b0f5-4446-9db4-fb2b06227a01.png?alt=media","htmlContent":"

While participating in clinical trials is an excellent way to participate in CLL research, it's not possible for every patient to do so.

\n\n

People living with CLL might live far away from an academic center, not fit typical qualifications for clinical trials, not have access to adequate transportation, or work a full-time job. They might have children or grandchildren to take care of at home or simply not be interested in a clinical trial at this time in their lives. These are just some of the barriers experienced by patients when considering a clinical trial.

\n\n

However, just because you can't participate in a clinical trial doesn't mean participating in CLL research is unattainable.

\n\n

By connecting your medical records to HealthTree Cure Hub, you are joining over 14,000 patients who have generously donated their anonymized data to be reviewed by researchers. More numbers in data portals such as this mean more accurate data for those investigators who are performing blood cancer research.

\n\n

Learn how to connect your records easily and quickly in the video below:

\n\n

WATCH HERE!

\n\n

How Can You Help?

\n\n

Participate in CLL research as or on behalf of a CLL patient by completing one of the following:

\n\n

Connect your medical records to our database in HealthTree Cure Hub today. It's quick and easy, and you can share your records with confidence that your personal information will be kept private. All information shared with researchers is anonymized. We value your privacy and your security.
Stay tuned to our News Website. Our goal this month is to help you be aware of research opportunities. We will publish articles regularly with action steps on how to participate and allow others to do the same.
Participate in surveys and studies within HealthTree Cure Hub. This can take 3-5 minutes of your time and influence the way healthcare providers treat CLL patients. Join HealthTree Cure Hub and start participating today.
Share this article with those in your CLL circle! The more people who know about and participate in real-world data research, the closer we are to better outcomes for CLL patients!

\n","language":"EN","metaDescription":"Many CLL patients don't qualify or can't participate in a clinical trial. But they can still impact CLL research through real-world data.","metaTitle":"Contribute to CLL Research with RWD","oldAuthor":{"_type":"DocumentReference","path":"apps/community/authors/dgpNLrVI0YJktfzGS0Ua"},"publishedAt":{"_type":"Date","value":"Thu May 09 2024 04:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"chronic lymphocytic leukemia, cll leukemia, real world data, impacting CLL research, participate in CLL research, how can i contribute to CLL research,","slug":"contribute-to-cll-research-with-rwd","status":"ACTIVE","title":"Can't Join a Clinical Trial? Contribute to Research with Real-World Data","updatedAt":{"_type":"Date","value":"Thu May 09 2024 23:10:49 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/AAXsmYQJMXy2huSdSiId"},"snapshot":{"exists":true,"id":"AAXsmYQJMXy2huSdSiId","ref":{"_type":"DocumentReference","path":"apps/community/articles/AAXsmYQJMXy2huSdSiId"}}},{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/GxAhXAnh3drV4xY5Vf3A-1620"},"categories":[{"_type":"DocumentReference","path":"apps/community/articleCategories/AJBVFq5YlnsCqpmYX3Nh"}],"category":{"_type":"DocumentReference","path":"apps/community/categories/BnXIg7Ru4SK5FpscX41b"},"createdAt":{"_type":"Date","value":"Mon Mar 11 2024 17:42:56 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/cll"},"diseases":[{"_type":"DocumentReference","path":"diseases/cll"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2Fdemographics_5fe1f43e-a22b-47e0-9327-5ea8934daff7.jpg?alt=media","htmlContent":"

This month, the HealthTree Foundation is focusing on raising awareness for quicker, more efficient blood cancer research. One of the best ways to accelerate cancer research is to understand how the patient population responds to different treatments. In order to best understand patient response, researchers need to understand who patients are.

\n\n

By filling out this 10-question, 3-minute demographic survey, you can aid researchers in answering key questions such as:

\n\n

Do certain races or ethnicities respond differently to a specific treatment than others?
Does marital status or city of origin influence disease progression?
How does environmental impact or military service affect diagnosis?

\n\n

This is especially important in achieving a cure not just for one demographic of patients but for all, regardless of race, ethnicity, gender, military service, city of origin, or education status.

\n\n

Help us achieve a cure for all by contributing your information in just three minutes!

\n\n

Take the Demographics Survey

\n\n

Please note that before shared with researchers, your data is anonymized. We value your privacy and are grateful for your contributions.

\n\n

If you have any questions or concerns about the survey, you can contact our HealthTree Patient Navigators (support@healthtree.org).

\n\n

If you don't have a HealthTree Cure Hub account, you can sign up for free today.

\n","language":"EN","metaDescription":"CLL patients are invited to take a ten-question, three-minute survey to help CLL researchers understand their demographic.","metaTitle":"Participate in CLL Research: Demographics Survey","migratedReason":"global-community","migratedReason2":"fix global-community categories","oldAuthor":{"_type":"DocumentReference","path":"apps/community/authors/dgpNLrVI0YJktfzGS0Ua"},"oldCategory":{"_type":"DocumentReference","path":"apps/community/categories/jB19cEpHSId89RF0gT1e"},"publishedAt":{"_type":"Date","value":"Wed May 08 2024 04:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"CLL research, how to participate in CLL research, how can i do CLL research, chronic lymphocytic leukemia, cll, cll cancer, cll leukemia, lymphocytic leukemia, chronic leukemia, lymphocytic, cll sll, cll disease, b cll, healthtree for cll, healthtree, leukemia disease, chronic lymphocytic leukemia, cll cancer, cll, leukemia cll, cll lymphocyte, chronic b cell leukemia, chronic b-cell leukemia, lymphocytic leukaemia, chronic leukaemia, chronic lymphocytic leukemia b cell, chronic lymphocytic leukemia cll, chronic lymphocytic leukaemia, b cell chronic lymphocytic leukemia, b-cell chronic lymphocytic leukemia, chronic lymphocytic leukemia b-cell, blood cancer cll, what is leukaemia, cancer of blood symptoms, cll leukemia, treatments of leukemia, chronic lymphocytic leukemia symptoms, cll cancer symptoms. cll symptoms, lymphocytic leukemia symptoms, chronic leukemia symptoms, cll leukemia symptoms, lymphocytic leukemia treatment, cll treatments, cll treatment, treatment for cll, treatments for cll leukemia, chronic lymphocytic leukemia treatment, treatment for chronic lymphocytic leukemia, treatment of chronic lymphocytic leukemia, lymphocytic definition, define lymphocytic, chronic leukemia treatment, treatment cll, treatments for cll, cll when to treat, treatment of cll, what level of lymphocytes is dangerous, define lymphocyte, lymphocytes meaning, medical abbreviation cll, cll abbreviation medical, what is chronic lymphocytic leukemia, what is cll, lymphocytic leukemia, what is lymphocytic leukemia, lymphatic leukaemia, cll medical abbreviation, define leukaemia, high lymphocytes means, leukaemia meaning, definition of leukemia, lymphocytes high meaning, lymphocytes high means, chronic leukemia, chronic blood cancer, chronic leukemias, what is lymphocytic, leukemia vs lymphoma, leukemia reason, blood test for leukemia, cll/sll, sll cll, sll/cll, how is leukemia detected, B cll, cll disease","slug":"participate-in-cll-research-demographics-survey","status":"ACTIVE","title":"Participate in CLL Research: Demographics Survey","updatedAt":{"_type":"Date","value":"Thu May 09 2024 00:22:53 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/nB1dt8PZIEZ9M6gLn21F"},"snapshot":{"exists":true,"id":"nB1dt8PZIEZ9M6gLn21F","ref":{"_type":"DocumentReference","path":"apps/community/articles/nB1dt8PZIEZ9M6gLn21F"}}},{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/GxAhXAnh3drV4xY5Vf3A-1620"},"categories":[{"_type":"DocumentReference","path":"apps/community/articleCategories/AJBVFq5YlnsCqpmYX3Nh"}],"category":{"_type":"DocumentReference","path":"apps/community/categories/BnXIg7Ru4SK5FpscX41b"},"createdAt":{"_type":"Date","value":"Mon Apr 22 2024 21:20:07 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/cll"},"diseases":[{"_type":"DocumentReference","path":"diseases/cll"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2Fspeeding%20research_2eb2a797-09fe-486d-a674-035324dffd02.jpg?alt=media","htmlContent":"

Clinical trials are an excellent way to collect data for CLL treatments and to get new therapies approved by the FDA. However, they are also long and costly.

\n\n

Why Does Clinical Trial Data Take So Long To Collect?

\n\n

Thankfully, patients are doing so well on therapies that progression-free survival and other primary endpoint data often take several years, even a decade or more, to collect.

\n\n

Additionally, the clinical trial process understandably requires time to fund, set up, be approved, enroll a sufficient number of patients, conduct the trial, and manage the complications, delays, and potential red tape that can come along the way. This can mean that from the time an investigator has a research idea to the time the clinical trial actually starts, it could be a matter of years.

\n\n

All of this time means millions of dollars are required to fund and support these trials. This often makes it unrealistic for a researcher to conduct an independent clinical trial rather than one that pharmaceutical companies fund.

\n\n

How Can Real-World Data Speed Up Research?

\n\n

Real-world studies allow data to be collected quickly and efficiently. What is taking years to collect in the clinical setting can take a mere matter of months.

\n\n

HealthTree Research Hub will allow rapid real-world data requests to be granted to blood cancer researchers to support meaningful and quicker studies.

\n\n

How?

\n\n

There is no time or cost in enrolling patients. Researchers are able to access a validated set of anonymized patient records that provide important information to answer their research requests.
Studies can be done retrospectively because the data researchers look for already exists. There is no need to wait for progression-free survival to be met.

\n\n

Blood cancer patients can't afford to wait years or decades to get better and personalized treatments that can improve their quality of life. Real-world data studies through HealthTree Research Hub can accelerate necessary investigations and surveys to significantly improve patient care and lead to better treatments and cures for each and every patient.

\n\n

Hear how blood cancer specialist, Dr. Irene Ghobrial, feels about HealthTree's research initiatives here:

\n\n

How Can You Help?

\n\n

Participate in CLL research as or on behalf of a CLL patient by completing one of the following:

\n\n

Connect your medical records to our database in HealthTree Cure Hub today. It's quick and easy, and you can share your records with confidence that your personal information will be kept private. All information shared with researchers is anonymized. We value your privacy and your security.
Stay tuned to our News Website. Our goal this month is to help you be aware of research opportunities. We will publish articles regularly with action steps on how to participate and allow others to do the same.
Participate in surveys and studies within HealthTree Cure Hub. This can take 3-5 minutes of your time and influence the way healthcare providers treat CLL patients. Join HealthTree Cure Hub and start participating today.
Share this article with those in your CLL circle! The more people know about and participate in real-world data research, the closer we are to better outcomes for CLL patients!

\n","language":"EN","metaDescription":"Real-world data can accelerate CLL research. Learn how through this article.","metaTitle":"Speeding Up CLL Research Through RWD ","oldAuthor":{"_type":"DocumentReference","path":"apps/community/authors/dgpNLrVI0YJktfzGS0Ua"},"publishedAt":{"_type":"Date","value":"Mon May 06 2024 04:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"real world data, acclerating research, clinical research, clinical research for cll, cll real world data","slug":"accelerated-research-with-rwd-cll","status":"ACTIVE","title":"Speeding Up the Research Process Using Real-World Data","updatedAt":{"_type":"Date","value":"Mon May 06 2024 17:13:56 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/D8QS9RKan0oi4QlSZd7t"},"snapshot":{"exists":true,"id":"D8QS9RKan0oi4QlSZd7t","ref":{"_type":"DocumentReference","path":"apps/community/articles/D8QS9RKan0oi4QlSZd7t"}}}],"categoryById":{"19hxT6XALz8ds00eORms":{"description":"Our Patient Stories articles contain patient and caregiver experiences, along with their advice for others going through similar circumstances.","metaDescription":"Read patient stories to learn about other’s experiences and what advice they have for people going through similar circumstances.","metaTitle":"Patient Stories - HealthTree Foundation","slug":"patient-stories","title":"Patient Stories"},"BnXIg7Ru4SK5FpscX41b":{"description":"Our HealthTree Research articles contain findings from surveys and studies inside HealthTree’s database. These surveys and studies are conducted by researchers and specialists.","metaDescription":"These articles are findings from HealthTree Research findings from surveys and studies.","metaTitle":"HealthTree Research - HealthTree Foundation","slug":"research","title":"HealthTree Research"},"MB3xw38fuKkx0LdszsrL":{"description":"Our Core Education articles help you understand your cancer so you are equipped to find a good care team, ask appropriate questions, and become your own best advocate.","metaDescription":"Learn 101 Education to help you know more about your cancer, what tests and treatments are available to you, and more.","metaTitle":"Core Education - HealthTree Foundation","slug":"core-education","title":"Core Education"},"SOL2ODcbaDI1CazQRbRS":{"description":"Read articles about HealthTree's progress in major media publications in video, online and in newspapers.","metaDescription":"These articles are about HealthTree's progress in major media publications in video, online and in newspapers.","metaTitle":"HealthTree Press - HealthTree Myeloma","slug":"healthtree-press","title":"HealthTree Press"},"WSTraX4hOKp92asdiTHa":{"description":"Our HealthTree Programs articles highlight the programs, events, and updates of the HealthTree Foundation.","metaDescription":"These articles highlight the programs, events, and updates of the HealthTree Foundation.","metaTitle":"HealthTree Programs - HealthTree Foundation","slug":"healthtree-programs","title":"HealthTree Programs"},"hUncpyMvyuZCF2qvA0Cv":{"description":"Our Clinical Trials articles highlight top clinical trials, their results, and how patients can participate in them.","metaDescription":"These articles highlight top clinical trials, their results, and how patients can participate in them.","metaTitle":"Clinical Trials - HealthTree Foundation","slug":"clinical-trials","title":"Clinical Trials"},"haqKTOi9lG4MNU3rNLG6":{"description":"Our Treatment Advances articles cover treatment option updates, new combinations of treatments, FDA approval news, and more.","metaDescription":"It's important for patients to stay up-to-speed on advancements in their cancer because the treatment options are rapidly changing.","metaTitle":"Treatment Advances - HealthTree Foundation","slug":"treatment-advances","title":"Treatment Advances"},"hn1DyzeAyX6tgl3gxSDx":{"description":"Our Navigating Your Health articles can help you proactively take control of your health through wellness news, financial updates, healthy recipes, and more.","metaDescription":"Learn tips related to your overall wellness, including your mental, physical, and emotional health.","metaTitle":"Navigating Your Health - HealthTree Foundation","slug":"navigating-your-health","title":"Navigating Your Health"},"j4bWXiDzhdlhMFvaeXoc":{"description":"Our Conferences articles contain the latest coverage of medical advancements from recent academic conferences.","metaDescription":"These articles discuss the latest coverage of medical advancements from recent academic conferences.","metaTitle":"Conferences - HealthTree Foundation","slug":"conferences","title":"Conferences"}},"categoryIdBySlug":{"clinical-trials":"hUncpyMvyuZCF2qvA0Cv","conferences":"j4bWXiDzhdlhMFvaeXoc","core-education":"MB3xw38fuKkx0LdszsrL","healthtree-press":"SOL2ODcbaDI1CazQRbRS","healthtree-programs":"WSTraX4hOKp92asdiTHa","navigating-your-health":"hn1DyzeAyX6tgl3gxSDx","patient-stories":"19hxT6XALz8ds00eORms","research":"BnXIg7Ru4SK5FpscX41b","treatment-advances":"haqKTOi9lG4MNU3rNLG6"},"defaultMetaDescription":"These articles are findings from HealthTree Research findings from surveys and studies.","defaultMetaTitle":"HealthTree Research - HealthTree Foundation","lastQueriedDoc":{"_type":"DocumentReference"},"reachedEnd":false,"trendingArticlesForWidget":[{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/NRcFf0ATixvpHmsyX2JM"},"categories":[],"category":{"_type":"DocumentReference","path":"apps/community/categories/hn1DyzeAyX6tgl3gxSDx"},"createdAt":{"_type":"Date","value":"Fri Jul 26 2024 21:39:45 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/cll"},"diseases":[{"_type":"DocumentReference","path":"diseases/leukemia"},{"_type":"DocumentReference","path":"diseases/lymphoblastic-lymphoma"},{"_type":"DocumentReference","path":"diseases/WGt6OKKh829p4KeZXIgE"},{"_type":"DocumentReference","path":"diseases/cll"},{"_type":"DocumentReference","path":"diseases/WCJo8IouncjDW6exT1YS"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2Fbruising_be6001da-8a4d-4998-82ec-35de09a19878.jpg?alt=media","htmlContent":"

The term leukemia can refer to different blood cancers. The type of leukemia depends on the blood cell affected and whether it grows quickly or slowly. While leukemia occurs most often in adults older than 55, it is also the most common cancer in children younger than 15.

\n\n

There are common findings that may indicate to health professionals that a person could have a blood disorder. A symptom that is commonly found in leukemia patients is red dots on the skin.

\n\n

Keep in mind that having red dots or any of the symptoms described below does not necessarily mean you have leukemia and, similarly, not all leukemia patients have skin symptoms.

\n\n

What Are The Common Skin Symptoms in Leukemia Patients?

\n\n

Many of the skin symptoms are a result of the blood cell imbalance that leukemia produces: red blood cells provide a rosy or reddish color to the skin, and white blood cells protect it from harmful substances. Platelets help keep healthy blood vessels from breaking and stop blood loss when, for example, a paper cut.

\n\n

When we have fewer red blood cells than normal, besides bodily symptoms, the skin can also be altered by losing the natural pinkish or reddish undertone.

\n\n

When we produce too many white blood cells, the ones protecting the skin may infiltrate creating an abnormal response like rashes or itching. However, having low platelet levels can also manifest in a rash-like area in the skin. This is why it’s very important to consult a trained healthcare professional to assess these skin changes and differentiate the rashes to properly treat them.

\n\n

\n\t
Small red dots (petechiae or purpura)
\n\t

\n\n

Petechiae are tiny red, purple, or brown spots under the skin caused by the rupture of small blood vessels called capillaries. They are very small and often found in arms and legs. When this bleeding affects larger areas under the skin, it is known as purpura. These symptoms occur due to low platelet levels, which impair the blood’s ability to clot.

\n\n

$\"\"$

\n\n

\n\t
Easy Bruising
\n\t

\n\n

This refers to bruising even with minor bumps. Bruises may appear in unusual places, such as the back or hands, and take longer to heal. Patients who experience this may not know how they got those bruises until they see them or experience tenderness from the lesion.

\n\n

We have a comprehensive article specifically on bruising, click here to read it.

\n\n

$\"\"$

\n\n

\n\t
Pale Skin (Anemia)
\n\t

\n\n

Leukemia can cause a decreased production of red blood cells, leading to anemia. One visible symptom of anemia is pale or grayish skin, a person can feel fatigue, weakness, and breathlessness when the red blood cells are abnormally low and, in severe cases, may require a blood transfusion.

\n\n

\n\t
Leukemia Cutis
\n\t

\n\n

Leukemia cutis is a rare condition affecting up to 3% of leukemia patients. It occurs when leukemia cells infiltrate the skin and cause lesions. These lesions can be purple or red-brown and appear under the skin like freckles or as small bloody blisters. They commonly appear in the legs, arms, back, chest, scalp, and face. Leukemia cutis usually appears after patients have been diagnosed with leukemia, but in rare cases, it can come before that.

\n\n

$\"\"$

\n\n

\n\t
Acute Myeloid Leukemia (AML) Rash
\n\t

\n\n

Like leukemia cutis, AML rashes result from acute myeloid leukemia cells invading the skin. Symptoms include discolored patches or bumps that may be raised or tender.

\n\n

\n\t
Mouth Sores
\n\t

\n\n

Leukemia can cause mouth problems such as swelling of the gums, bleeding, ulcers, and petechiae in the mouth. Patients may also experience oral infections and reduced jaw mobility.

\n\n

\n\t
Sweet Syndrome or Febrile neutrophilic dermatosis
\n\t

\n\n

It is a rare disorder characterized by inflamed skin lesions caused when a type of blood cell called neutrophil infiltrates the skin. It can also cause eye lesions or inflammation and often comes with fever, joint pain, headaches, and fatigue. The skin lesions typically affect the arms and upper body and can be managed with steroid treatment.

\n\n

\n\t
Mastocytosis
\n\t

\n\n

Mast cells are immune cells located in the skin, they have granules that, under stress or foreign substances, are released and produce flushing, itching, and swelling in the skin. When an excess amount of mastocytes are activated (mastocytosis), the symptoms resemble an allergic reaction and can be treated with antihistamines.

\n\n

When Should You Seek Professional Help?

\n\n

Rashes and other skin issues can have many causes. However, it’s important to follow your gut and listen to your body if you think there is something out of the ordinary. Some signs that might seem odd but don’t have discomfort can also hide a more serious condition. So, to prevent any complications, it’s important to seek help from a trained health professional who can identify these symptoms and give you an accurate diagnosis.

\n\n

Notice increased bleeding or bruising.
Develop purple patches on the skin.
Experience frequent mouth sores.
Have accompanying symptoms like fatigue.

\n\n

These could be early signs of a blood disorder or indications that treatment adjustments are necessary for those already diagnosed.

\n\n

Frequently Asked Questions

\n\n

What does a leukemia rash look like? Leukemia rashes appear as tiny red spots or purple areas that do not fade when pressed, these are caused by low platelet levels and the rupture of very small blood vessels in the skin. These spots are also known as petechiae or purpura, depending on their size.
What does leukemia bruising look like? Leukemia bruises may occur more easily and in unusual places, often accompanied by petechiae or purpura.
Is a rash a symptom of leukemia? Yes, it could be linked to leukemia, but rashes are also a symptom of other diseases and conditions. The diagnosis has to be determined by a health professional after examination and questioning of a patient’s overall health. Petechiae and purpura can be early signs of leukemia, though they can also result from other conditions.
Where does a leukemia rash appear first? Rashes commonly start on the chest, abdomen, legs, and arms.
Are leukemia rashes itchy? They can be itchy in some cases, but not always.

\n\n

Understanding these skin changes can help patients and caregivers recognize early symptoms of leukemia and seek timely medical advice. If you experience any of these symptoms, consult with your healthcare provider for proper diagnosis and treatment.

\n\n

Accelerate the Discovery of New Treatment Options by Connecting Your Records to HealthTree Cure Hub!

\n\n

If you are interested in participating in or finding a clinical trial, locating a leukemia specialist, or staying informed about updates on leukemia, you can create a free HealthTree Cure Hub account!

\n\n

CREATE YOUR FREE ACCOUNT

\n\n

Sources:

\n\n

\n","language":"EN","metaDescription":"Learn about the common skin symptoms of leukemia, including petechiae, bruising, and more. Recognize early signs and when to consult a doctor.","metaTitle":"Recognizing Skin Symptoms in Leukemia Patients","oldAuthor":{"_type":"DocumentReference","path":"apps/community/authors/tqkNFIHHZLwD2SNpAKDv"},"publishedAt":{"_type":"Date","value":"Wed Aug 14 2024 04:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"petechiae, purpura, purpurae, thrombocytopenia, leukemia cutis, aml rash, skin lesions, cancer skin lesions, skin rash, bruise, easy bruising, mastocytosis, sweet syndrome, Febrile neutrophilic dermatosis ","slug":"skin-lesions-in-leukemia","status":"ACTIVE","title":"Red Spots on the Skin, a Sign of Leukemia? ","updatedAt":{"_type":"Date","value":"Tue Aug 20 2024 13:42:14 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/d7emC9VJeATpHTEOCGRE"},"snapshot":{"exists":true,"id":"d7emC9VJeATpHTEOCGRE","ref":{"_type":"DocumentReference","path":"apps/community/articles/d7emC9VJeATpHTEOCGRE"}}},{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/dtN24frUcPS1CRElyXh1"},"category":{"_type":"DocumentReference","path":"apps/community/categories/MB3xw38fuKkx0LdszsrL"},"createdAt":{"_type":"Date","value":"Tue Oct 01 2024 23:20:50 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/cll"},"diseases":[{"_type":"DocumentReference","path":"diseases/cll"}],"headerImageUrl":"https://healthtree.org/images-resize?imageUrl=https%253A%252F%252Ffirebasestorage.googleapis.com%252Fv0%252Fb%252Fhealthtree-production.appspot.com%252Fo%252Fgallery%25252Fpublic%25252FScreen%252520Shot%2525202024-09-27%252520at%25252010.32.28%252520AM_d06237a8-1fce-4cd7-90d6-7d8c96f08f3a.png%253Falt%253Dmedia","htmlContent":"

Although chemotherapy is no longer the standard of care for CLL/SLL, learn about certain cases in which it may still be used for people with this cancer.

Is Chemotherapy Used for CLL?

As of the mid-2000s, chemotherapy (a form of cancer treatment that kills quickly dividing cells) is now rarely used to treat chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). This is because modern targeted therapies such as BTK inhibitors and venetoclax have proven to be far superior in their effectiveness over chemotherapy for these patients and have fewer treatment-related side effects.

It is important to know that this field is advancing and changing constantly, and general oncologists might not always know the latest recommendations for your specific type of cancer. Please speak with a CLL specialist to help evaluate your treatment options. Need help finding one?

Click here to review HealthTree’s specialist directory

However, some people with CLL/SLL may have received chemotherapy regimens even since targeted therapies have become the new standard of care. Although rarely used, this article will discuss some of the cases in which chemotherapy regimens are still considered to treat CLL/SLL.

When Chemotherapy May Still Be Considered to Treat CLL/SLL

Cases in which chemotherapy may be recommended to treat CLL/SLL include:

\n
You are unable to be treated with targeted therapies and are not eligible to join clinical trials
\n
\n
A quick response to treatment is needed
\n
\n
Other treatments you tried were not successful
\n
\n
You receive chemotherapy as a pre-treatment for another therapy like CAR T-cells or a stem cell transplant
\n
\n
People with CLL who have experienced Richter transformation may have been treated with chemotherapy regimens in the past. Specialists are finding that chemotherapy is not an effective option for these patients. To learn more about Richter transformation and improved treatment options, click here
\n
\n
Limited resources: Certain parts of the world may not have access to targeted therapies for CLL/SLL, and chemotherapy is still used. Traveling to a location that administers targeted therapies for CLL may help overcome this obstacle
\n

What Types of Chemotherapy are Used for CLL/SLL?

Types of chemotherapy combinations for people with CLL/SLL may include:

\n
Fludarabine, cyclophosphamide, and rituximab (FCR)
\n
\n
Bendamustine and rituximab (BR)
\n

These treatments are administered intravenously (via an IV). A timeline example for an infusion would be:

\n
Bendamustine (chemotherapy) is administered intravenously over 10 minutes on the first and second days of each month for up to 6 months
\n
\n
Rituximab (monoclonal antibody given alongside the chemotherapy) is administered intravenously over 3-4 hours on the first day of each month for 6 months
\n

Common side effects may include low blood counts, hair loss, mouth sores, loss of appetite, nausea, and vomiting. Ask your doctor about ways to manage side effects. You can also click here to learn about side effect management strategies recommended by other patients.

One thing to note is that people with CLL/SLL who have a del(17p)/TP53 mutation do not have favorable outcomes with chemotherapy. If you have this type of CLL, ask your doctor about clinical trials you may be eligible to join. You can also click here to learn about other treatment options available if you are not eligible for standard CLL care.

!AD!

Conclusion

In summary, although chemotherapy is now rarely used for people with CLL/SLL, certain circumstances may place it as a treatment option. Some of these cases include if standard CLL therapies have not worked, if you are preparing to receive CAR T-cell therapy, or if you are preparing for a stem cell transplant. Talk with your CLL specialist to identify the best treatment for you.

Stay updated with the latest news on research and treatment of CLL with HealthTree for CLL. Subscribe to our CLL Newsletter today!

CLL Newsletter

!AD!

Sources:

\n
Chemotherapy for Chronic Lymphocytic Leukemia (CLL)
\n
\n
Practical Management of Richter Transformation in 2023 and Beyond
\n
\n
Typical Treatment of Chronic Lymphocytic Leukemia
\n
\n
AbbVie News Center
\n
\n
Bendeka (Bendamustine) Prescribing Information
\n
\n
Rituxan (Rituximab) Prescribing Information
\n

","language":"EN","metaDescription":"Learn about special circumstances in which chemotherapy may be used to treat chronic lymphocytic leukemia (CLL).","metaTitle":"Is Chemotherapy Used to Treat CLL/SLL?","publishedAt":{"_type":"Date","value":"Thu Sep 26 2024 06:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"Is chemo used for CLL, is chemotherapy used for chronic lymphocytic leukemia, chemo and CLL, chemo and SLL, BR CLL, FCR CLL, R-CHOP Richter transformation, R-CHOP RT, R-EPOCH Richter transformation, R-EPOCH RT, Fludarabine CLL, cyclophosphamide CLL, bendamustine CLL, double refractory cll treatments, chemo cll, cll chemo success rate, cll chemo pill, cll chemo regimen, cll chemo treatment side effects, cll chemo tablets, chemo medication for cll, chemo infusion for cll, CLL news, chronic lymphocytic leukemia, small lymphocytic lymphoma, cll sll, sll, healthtree ","slug":"is-chemotherapy-used-to-treat-cll-sll","status":"ACTIVE","title":"Is Chemotherapy Used to Treat CLL/SLL?","updatedAt":{"_type":"Date","value":"Tue Oct 01 2024 23:38:44 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/BGoIqGbrQlSRwbb5sVQA"},"snapshot":{"exists":true,"id":"BGoIqGbrQlSRwbb5sVQA","ref":{"_type":"DocumentReference","path":"apps/community/articles/BGoIqGbrQlSRwbb5sVQA"}}},{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/Yj5pk904HRNwZA8Wqfcu"},"category":{"_type":"DocumentReference","path":"apps/community/categories/hn1DyzeAyX6tgl3gxSDx"},"createdAt":{"_type":"Date","value":"Mon Sep 09 2024 14:16:38 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},"diseases":[{"_type":"DocumentReference","path":"diseases/GMiulNhUPGrzlsCN3Fmv"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2Fbcam%20banner_2c6c301d-d5f7-48bb-9049-bf5978a1f9a7.png?alt=media","htmlContent":"

Blood cancers, a group of cancers affecting the blood and bone marrow, often present with subtle symptoms that can be easily overlooked. Early detection is key to improving outcomes and increasing treatment success rates. This Blood Cancer Awareness Month, we're empowering you with the knowledge to recognize potential warning signs and take proactive steps for your health.

\n\n

Common Symptoms to Watch For

\n\n

While blood cancers can manifest in various ways, some common symptoms include:

\n\n

Unexplained fatigue: Feeling unusually tired or weak, even after adequate rest.
Sudden weight loss: Losing a significant amount of weight without any changes in diet or exercise.
Frequent infections: Experiencing more infections than usual or taking longer to recover.
Easy bruising or bleeding: Noticing bruises or bleeding easily, even from minor injuries.
Swollen lymph nodes: Feeling enlarged lymph nodes in the neck, armpits, or groin.
Bone pain: Experiencing persistent pain in the bones, often in the back or ribs.
Changes in the skin, such as unexplained rashes, itchy skin, or a sore that does not seem to heal
Frequent fevers or experiencing night sweats on a regular basis
Persistent headaches, difficulty breathing, feeling faint or lightheaded, or noticing a rapid or irregular heartbeat

\n\n

Don't Ignore the Signs

\n\n

If you experience any of these symptoms, it's essential to consult your doctor promptly. While other conditions can cause these symptoms, it's crucial to rule out blood cancer as a possibility.

\n\n

Early diagnosis is crucial as it often allows for more treatment options and better outcomes. When blood cancers are detected at later stages, they may have already caused significant damage to the body, making treatment more complex and potentially less effective. In some cases, a delayed diagnosis can limit access to treatments like stem cell transplants, which are often most successful when performed earlier in the disease course.

\n\n

!AD!

\n\n

Taking Action: Knowledge is Power

\n\n

This September, join HealthTree Foundation for our upcoming "Innovation in Blood Cancer" webinar on September 30th. This informative session will feature a panel of experts in hematology who will discuss the latest advancements in blood cancer research, treatment, and care. The webinar is free and open to all patients and their loved ones.

\n\n

webinar registration

\n\n

!AD!

\n\n

By staying informed and proactive, we can work together to improve early detection rates and support those affected by blood cancer.

\n\n

HealthTree Foundation: Innovation that Saves Lives

\n\n

!AD!

\n","language":"EN","metaDescription":"Understanding the common symptoms of blood cancer is crucial for early detection and treatment. Learn more about the signs and how to take action.","metaTitle":"Commons Signs and Symptoms of Blood Cancer","publishedAt":{"_type":"Date","value":"Wed Sep 11 2024 04:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"blood cancer symptoms, blood cancer diagnosis, blood cancer signs, early detection, blood cancer awareness, health checkup, blood cancer webinar","slug":"bcam-2024-blood-cancer-signs-and-symptoms","status":"ACTIVE","title":"Blood Cancer Awareness: Recognizing the Signs and Taking Action","updatedAt":{"_type":"Date","value":"Thu Sep 26 2024 21:09:15 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/i2PWC3RgkAUzBWNY20Vz"},"snapshot":{"exists":true,"id":"i2PWC3RgkAUzBWNY20Vz","ref":{"_type":"DocumentReference","path":"apps/community/articles/i2PWC3RgkAUzBWNY20Vz"}}},{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/Yj5pk904HRNwZA8Wqfcu"},"categories":[],"category":{"_type":"DocumentReference","path":"apps/community/categories/hn1DyzeAyX6tgl3gxSDx"},"createdAt":{"_type":"Date","value":"Tue Aug 20 2024 17:12:04 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/WCJo8IouncjDW6exT1YS"},"diseases":[{"_type":"DocumentReference","path":"diseases/WCJo8IouncjDW6exT1YS"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FScreen%20Shot%202024-06-21%20at%2010.19.38%20AM_d4d3569f-a0f5-4a5b-819f-7297420b443a.png?alt=media","htmlContent":"

Acute myeloid leukemia (AML) is a cancer that affects the bone marrow, where blood cells are made. While the disease primarily affects blood cell production, it can also indirectly impact other organs, including the kidneys. This impact can stem from the disease itself or from the therapies used to treat it.

\n\n

How AML and Its Treatments Can Affect Your Kidneys

\n\n

AML's Direct Impact

\n\n

In some cases, AML can directly affect the kidneys. This can occur in around 30% of patients with AML when leukemia cells infiltrate the kidneys, hindering their ability to filter waste products from the blood. While this is less common than treatment-related kidney issues, it's a possibility, especially in patients with a high white blood cell count at diagnosis. One study found that a high white blood cell count significantly increased the risk of kidney complications in AML patients.

\n\n

Treatment-Related Impact

\n\n

Chemotherapy drugs, a cornerstone of AML treatment, can sometimes damage the kidneys. These powerful medications are designed to kill cancer cells but can also harm healthy cells in the process. The kidneys, responsible for filtering medications from the bloodstream, are particularly vulnerable.

\n\n

In addition to chemotherapy, other AML treatments like bone marrow transplantation can also pose risks to kidney health. Medications used to prevent complications after transplantation, such as immunosuppressants, antibiotics, or antifungals, can also potentially impact kidney function.

\n\n

Immunotherapies, like immune checkpoint inhibitors and CAR T-cell therapy, can also potentially lead to kidney inflammation and damage, though this is less common than with chemotherapy.

\n\n

It's important to note that not everyone with AML will experience kidney problems. However, understanding the potential risks is crucial for early detection and management.

\n\n

Recognizing the Signs of Kidney Impairment

\n\n

Kidney problems often develop gradually, with symptoms appearing only when significant damage occurs. Being aware of these symptoms is vital:

\n\n

Fatigue: Feeling unusually tired and lacking energy.
Swelling: Noticeable swelling in the legs, ankles, feet, face, or hands due to fluid retention.
Changes in urination: Increased or decreased urine output, foamy urine, or difficulty urinating.
Shortness of breath: Difficulty breathing, especially when lying down, due to fluid buildup in the lungs.
Nausea and vomiting: Feeling sick to your stomach and experiencing vomiting.

\n\n

You must contact your healthcare team if you experience any of these symptoms. Early detection and treatment of kidney problems are crucial for preventing further complications.

\n\n

!AD!

\n\n

Understanding Kidney Complications

\n\n

When discussing kidney problems, you might come across various medical terms that sound complicated. To help clarify, let's break down a few common terms you might encounter in your healthcare journey:

\n\n

Kidney impairment: A general term indicating reduced kidney function. This can range from mild to severe.
Kidney failure: A severe condition where the kidneys can no longer effectively filter waste from the blood. This can be acute (sudden onset) or chronic (long-term).\n\t
- Acute Kidney Injury (AKI): A sudden and often reversible decline in kidney function. AKI is a serious condition that requires prompt medical attention.
- Chronic Kidney Disease (CKD): A long-term condition characterized by a gradual and irreversible decline in kidney function over time.
\n\t

\n\n

$\"\"$

\n\n

Managing Kidney Problems in AML Patients

\n\n

Treatment for kidney complications in AML patients depends on the underlying cause and severity. Options may include:

\n\n

Adjusting medications: If a medication is suspected to be causing kidney problems, your doctor may adjust the dosage or switch to a different drug.
Intravenous fluids: In cases of dehydration or volume depletion, intravenous fluids may be administered to support kidney function.
Medications to control blood pressure and potassium levels: Medications may be prescribed to manage high blood pressure and elevated potassium levels, which can further strain the kidneys.
Dialysis: In severe cases of kidney failure, dialysis may be necessary to filter waste products from the blood.

\n\n

Treating kidney problems in AML patients can be complex, as decisions must consider both the kidney condition and the underlying cancer. Close collaboration between your oncology team and a kidney specialist (nephrologist) is essential for developing an individualized treatment plan.

\n\n

!AD!

\n\n

Impact of Kidney Injury on AML Treatment and Survival

\n\n

Kidney problems can significantly impact the course of AML treatment and overall survival. Studies have shown that patients with pre-existing kidney impairment or those who develop kidney injury during treatment may have:

\n\n

Lower response to chemotherapy: Kidney problems can affect the body's ability to process and eliminate chemotherapy drugs, potentially reducing their effectiveness.
Increased risk of treatment complications: Patients with kidney issues may be more susceptible to infections and other complications from chemotherapy or bone marrow transplantation.
Poorer overall survival: Several studies have linked kidney problems in AML patients to a less favorable prognosis and decreased survival rates. However, other factors like AML subtype or percentage of blasts have a more significant weight than kidney function.

\n\n

It's crucial to remember that every patient is different, and the impact of kidney problems can vary widely. Close monitoring of kidney function, early intervention, and careful management of both AML and kidney health are essential for improving outcomes.

\n\n

!AD!

\n\n

Take Charge of Your Health Journey

\n\n

Empower yourself by creating a free account on HealthTree Cure Hub. Explore personalized treatment options and clinical trials, track your disease and lab results, and participate in research—all in one place. Join a community dedicated to advancing AML care and improving outcomes. Visit HealthTree Cure Hub to get started today and become a Cure Contributor!

\n\n

Sources:

\n\n

\n","language":"EN","metaDescription":"AML and its treatments can impact kidney health. Learn about the risks, symptoms & treatment options for kidney problems in AML patients.","metaTitle":"AML and Kidney Health: Risks and Impacts","oldAuthor":{"_type":"DocumentReference","path":"apps/community/authors/qUEcufzaaVuCtRTS9oSc"},"publishedAt":{"_type":"Date","value":"Fri Aug 30 2024 04:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"acute myeloid leukemia, AML, kidney disease, kidney failure, acute kidney injury, kidney impairment, AML treatment, kidney health, creatinine, dialysis, aml prognosis, aml patients, healthtree for aml, myeloid leukemia, acute leukemia, leukemia complications, can leukemia affect my kidneys","slug":"aml-kidney-injury","status":"ACTIVE","title":"Acute Myeloid Leukemia and Your Kidneys: What You Need to Know","updatedAt":{"_type":"Date","value":"Tue Aug 20 2024 22:12:07 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/RYXimGFuUKdIl7LVCFT5"},"snapshot":{"exists":true,"id":"RYXimGFuUKdIl7LVCFT5","ref":{"_type":"DocumentReference","path":"apps/community/articles/RYXimGFuUKdIl7LVCFT5"}}},{"data":{"author":{"_type":"DocumentReference","path":"apps/community/authors/NRcFf0ATixvpHmsyX2JM"},"category":{"_type":"DocumentReference","path":"apps/community/categories/hn1DyzeAyX6tgl3gxSDx"},"createdAt":{"_type":"Date","value":"Thu Sep 12 2024 19:43:56 GMT+0000 (Coordinated Universal Time)"},"disease":{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"},"diseases":[{"_type":"DocumentReference","path":"diseases/WCJo8IouncjDW6exT1YS"},{"_type":"DocumentReference","path":"diseases/tDYO4O8HTJT5dAHT6xis"},{"_type":"DocumentReference","path":"diseases/eBIxYtdHAYhTTs5L9bcC"},{"_type":"DocumentReference","path":"diseases/burkitts-lymphoma"},{"_type":"DocumentReference","path":"diseases/cll"},{"_type":"DocumentReference","path":"diseases/GxAhXAnh3drV4xY5Vf3A"}],"headerImageUrl":"https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2Ftumor%20lysis%20syndrome_339bd748-b162-4f05-a301-73f198dff1ee.jpg?alt=media","htmlContent":"

Tumor Lysis Syndrome (TLS) is one of the most critical and common oncologic emergencies. It occurs when cancer cells break down rapidly, releasing their contents into the bloodstream. This sudden release can overwhelm the body, leading to organ damage. It can develop spontaneously or more commonly after beginning cancer treatments, such as chemotherapy, especially in patients affected by tumor side effects. Both adults and children with cancer are susceptible to experiencing TLS.

\n\n

Why is Tumor Lysis Syndrome Dangerous?

\n\n

TLS can cause body electrolytes to drop or increase, leading to life-threatening conditions, including:

\n\n

Acute Kidney Injury (AKI): Excessive uric acid and other substances can accumulate, leading to kidney dysfunction or failure.
Heart arrhythmias: Elevated potassium levels (hyperkalemia) can disrupt heart rhythms, potentially leading to cardiac arrest.
Low calcium levels or hypocalcemia:Can cause muscle cramps, seizures, and other severe complications.

\n\n

Who is at Risk for Tumor Lysis Syndrome?

\n\n

While tumor lysis syndrome is most commonly associated with leukemia and high-grade lymphomas (listed below), it can also occur in solid tumors, particularly after aggressive chemotherapy. Rarely, TLS can occur spontaneously before any treatment is initiated.

\n\n

Although TLS can occur in various cancer types, it is most frequently associated with:

\n\n

High-risk tumors: Advanced Burkitt lymphoma, acute lymphocytic leukemia (ALL) with very high white blood cell (WBC) counts, and diffuse large B-cell lymphoma (DLBCL) with elevated lactate dehydrogenase (LDH) levels.
Intermediate-risk tumors: Acute myeloid leukemia with moderate WBC counts, certain types of lymphomas, and less aggressive forms of leukemia, are still at risk but to a lesser extent.
Low-risk tumors: These include chronic lymphocytic leukemia (CLL), solid tumors, multiple myelomas, and indolent lymphomas, though they are less commonly associated with TLS.

\n\n

What are Tumor Lysis Syndrome’s Signs and Symptoms?

\n\n

Patients experiencing TLS may present with a range of symptoms, including:

\n\n

Nausea, vomiting, and diarrhea
Muscle cramps and weakness
Seizures or altered mental status
Difficulty breathing
Irregular heart rhythms

\n\n

How is Tumor Lysis Syndrome Diagnosed?

\n\n

Early diagnosis of TLS is crucial for effective treatment. Healthcare providers monitor patients for key indicators, including:

\n\n

Blood tests: Monitoring of electrolytes such as potassium, phosphate, calcium, and uric acid levels.
Kidney function tests: To assess kidney performance and detect early signs of damage, tests can be performed by blood (analyzing blood chemistry), or a 24-hour collection of urine analysis can give a more accurate diagnosis.
Heart monitoring: To detect any change in your heart rhythm that may result from electrolyte imbalances.

\n\n

What Therapies Can Cause Tumor Lysis Syndrome?

\n\n

Therapies that can rapidly kill cancer cells, for example; chemotherapy, and some combinations especially combined with agents such as venetoclax or obinutuzumab, radiation therapy, corticosteroids, targeted therapy, hormonal therapy and biological therapy.

\n\n

TLS as many adverse events, depends on the body’s ability to respond to each therapy and the way in which they are administered. In theory, all treatments that target cancer cells to be destroyed have a risk of presenting tumor lysis syndrome. You can talk to your cancer specialist about specific concerns regarding your treatment.

\n\n

How is Tumor Lysis Syndrome Treated?

\n\n

Treatment of tumor lysis syndrome focuses on correcting the metabolic imbalances and protecting vital organs.

\n\n

Hydration: Proper hydration is essential to help flush out excess electrolytes and waste products from the kidneys. Drinking plenty of water before and during treatment can help prevent TLS. Intravenous (IV) fluids may also be administered to ensure proper hydration.
Medications:\n\t
- Allopurinol: This medication is commonly used to reduce uric acid levels in the blood, which can accumulate during TLS. It is often started a few days before treatment and continued until the risk has passed.
- Rasburicase: In high-risk patients, rasburicase may be used instead of or in addition to allopurinol. Rasburicase breaks down uric acid into a more easily excreted substance, helping to prevent kidney damage.
- Electrolytes: Medications may be prescribed to manage specific electrolyte imbalances, such as potassium binders; when potassium levels are too high (hyperkalemia), or phosphate binders to decrease high levels of phosphate in the blood (hyperphosphatemia).
\n\t
Close monitoring: Patients at risk for TLS require close monitoring of their blood chemistry, especially during the first few days of treatment. Regular blood tests check levels of uric acid, potassium, calcium, and phosphate, allowing for prompt intervention if imbalances occur.
Gradual dose escalation: For therapies like venetoclax, a gradual dose escalation schedule is often employed to reduce the risk of TLS. Starting with a lower dose allows the body to adapt to the treatment, minimizing the sudden release of cellular contents.
Dialysis: In severe cases where tumor lysis syndrome leads to kidney failure or life-threatening electrolyte imbalances, dialysis may be necessary to remove excess waste products and stabilize the patient's condition.

\n\n

Can Tumor Lysis Syndrome Be Prevented?

\n\n

For patients at high risk of developing TLS, preventive measures are essential:

\n\n

Preventive treatment: Medications to reduce uric acid levels and protect kidneys are often started before initiating chemotherapy.
Close monitoring: High-risk patients require vigilant monitoring during and after cancer treatment to catch any early signs of TLS.

\n\n

Preventing and managing tumor lysis syndrome requires a coordinated effort from an interprofessional team, including oncologists, nephrologists, critical care specialists, and nurses. Early diagnosis, rapid intervention, and continuous monitoring are key to improving patient outcomes.

\n\n

Tumor Lysis Syndrome is a life-threatening condition that demands immediate medical attention. Recognizing the early signs of tumor lysis syndrome can significantly reduce the risk of severe complications. For patients undergoing cancer treatment, regular monitoring and close contact with their healthcare team can ensure the best possible outcomes.

\n\n

Accelerate the discovery of new treatment options by creating an account at HealthTree Cure Hub, an innovative tool that powers life-saving research!

\n\n

If you are interested in finding a clinical trial, locating a specialist, or staying on top of your health by reading comprehensive news about your disease, you can create a free HealthTree Cure Hub account!

\n\n

CREATE MY FREE ACCOUNT

\n\n

Source:

\n\n

Tumor lysis syndrome

\n\n

\n","language":"EN","metaDescription":"Learn about Tumor Lysis Syndrome (TLS), a life-threatening oncologic emergency caused by rapid cancer cell breakdown leading to affected body functions.","metaTitle":"What is Tumor Lysis Syndrome?","publishedAt":{"_type":"Date","value":"Fri Sep 13 2024 06:00:00 GMT+0000 (Coordinated Universal Time)"},"seoKeywords":"tumor lysis syndrome, oncologic emergency, blood cancer, chemotherapy side effects, chemo adverse effects, adverse effects from cancer therapies, Tumor Lysis Syndrome, oncologic emergency, cancer treatment complications, acute kidney injury, hyperkalemia, uric acid levels, electrolyte imbalances, leukemia, high-grade lymphomas, Burkitt lymphoma, diffuse large B-cell lymphoma, chemotherapy side effects, venetoclax therapy, rasburicase treatment, cancer patient monitoring, TLS prevention","slug":"what-is-tumor-lysis-syndrome","status":"ACTIVE","title":"What is Tumor Lysis Syndrome?","updatedAt":{"_type":"Date","value":"Wed Sep 25 2024 14:47:32 GMT+0000 (Coordinated Universal Time)"}},"included":{},"ref":{"_type":"DocumentReference","path":"apps/community/articles/BO7KbvCM1CA0wSIOagID"},"snapshot":{"exists":true,"id":"BO7KbvCM1CA0wSIOagID","ref":{"_type":"DocumentReference","path":"apps/community/articles/BO7KbvCM1CA0wSIOagID"}}}],"upcomingEventsForWidget":[]}

HealthTree Cure Hub: Accelerating Cures Through Patient-Driven Research

Real-World Impact: Examples of HealthTree Research

Participate in Blood Cancer Research, Become a Cure Contributor

Empowering Patients Through Knowledge and Connection

Expanding Support for All Blood Cancers

Benefits of HealthTree Cure Hub for CLL Patients

How To Share HealthTree Cure Hub Within Your CLL Circle

How Can I Take These Surveys?

My Current Health

Health History: Heart and Lungs

Heart and Metabolic Family History

Cancer Family History

Health History: General and Immune

Health History: Kidney, Intestines, Skeletal, etc.

Health History: Surgeries, Other Cancers, Mental Health

Do Diet and Alternative Therapies Influence CLL Progression? Help Us Find Out!

How Can You Help?

Why Does Clinical Trial Data Take So Long To Collect?

How Can Real-World Data Speed Up Research?

How Can You Help?

What Are The Common Skin Symptoms in Leukemia Patients?

Small red dots (petechiae or purpura)

Easy Bruising

Pale Skin (Anemia)

Leukemia Cutis

Acute Myeloid Leukemia (AML) Rash

Mouth Sores

Sweet Syndrome or Febrile neutrophilic dermatosis

Mastocytosis

When Should You Seek Professional Help?

Frequently Asked Questions

Accelerate the Discovery of New Treatment Options by Connecting Your Records to HealthTree Cure Hub!

Is Chemotherapy Used for CLL?

When Chemotherapy May Still Be Considered to Treat CLL/SLL

What Types of Chemotherapy are Used for CLL/SLL?

Conclusion

Common Symptoms to Watch For

Don't Ignore the Signs

Taking Action: Knowledge is Power

How AML and Its Treatments Can Affect Your Kidneys

Recognizing the Signs of Kidney Impairment

Understanding Kidney Complications

Managing Kidney Problems in AML Patients

Impact of Kidney Injury on AML Treatment and Survival

Take Charge of Your Health Journey

Why is Tumor Lysis Syndrome Dangerous?

Who is at Risk for Tumor Lysis Syndrome?

What are Tumor Lysis Syndrome’s Signs and Symptoms?

How is Tumor Lysis Syndrome Diagnosed?

What Therapies Can Cause Tumor Lysis Syndrome?

How is Tumor Lysis Syndrome Treated?

Can Tumor Lysis Syndrome Be Prevented?